X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
At a glance
All your medicines and their interactions in one place — free in the brite app.
COVID-19 is the illness caused by the coronavirus SARS-CoV-2. The virus did not disappear when the pandemic ended; it now circulates permanently in the population — experts describe this as an endemic situation with seasonal waves, similar to flu or RSV.¹
The decisive difference from 2020: almost everyone has by now built up some basic immunity, through vaccination, past infections or both. That is why an infection today usually runs a far milder course than in the first years of the pandemic. This does not make COVID-19 harmless — for older people and for people with a weakened immune system the infection can still become dangerous, and it is precisely for these groups that effective antiviral medicines now exist.
Since the end of 2021 all circulating virus variants have descended from the Omicron line. These descendants keep changing, but they differ little from one another in the way the illness runs: they mainly affect the upper airways and reach the lungs less often than earlier variants did.¹ Broadly, four courses can be distinguished:
A typical mild illness starts one to four days after infection with a scratchy throat and fatigue, peaks after two to three days and then slowly settles. Cough and exhaustion can linger for another one to two weeks even after a mild course — on its own, that is not yet Long COVID.
Symptoms alone cannot reliably tell COVID-19 apart from flu, RSV or a common cold — that needs a test. The guide Cold, flu or COVID? offers help with that decision during the winter months.
For the great majority of healthy adults, COVID-19 is now something you get through without much trouble. A higher risk of severe illness applies above all to:¹
This classification is more than statistics: it decides whether antiviral treatment should be considered when an infection occurs — and for that, every day counts (more on this in section 7).
SARS-CoV-2 spreads mainly through droplets and aerosols — the finest suspended particles produced when we breathe, speak, sing and cough. In closed, poorly ventilated rooms aerosols build up, which is why most infections happen indoors. The time between infection and first symptoms (the incubation period) is usually only one to four days with the current variants. As a rule you are already infectious shortly before symptoms begin, and most infectious during the first days of the illness.¹
Whether an infection turns severe depends not only on age and pre-existing conditions but also on medicines that dampen the immune system:
The diagnosis today almost always rests on rapid antigen tests or a PCR test:²
For healthy adults without risk factors the rule is simple: COVID-19 is treated like any other respiratory infection — symptomatically, with rest and patience. An antiviral is usually not needed here according to the guideline, because the immune system controls the infection itself.³
For people at higher risk there are antiviral medicines that slow down viral replication and have been shown to reduce the risk of hospital admission. The most important one is nirmatrelvir/ritonavir (brand name Paxlovid) — tablets taken over five days.³,⁴ For the treatment to work it has to start within five days of symptom onset; the earlier, the better.
It is usually an option for adults with mild to moderate illness who are at increased risk of a severe course — that is, the groups listed in section 3. Whether it makes sense in an individual case is decided by the treating practice. For selected situations remdesivir is available as an infusion instead; molnupiravir was not granted a marketing authorisation in the EU.³
The ritonavir component of Paxlovid blocks a central metabolising enzyme in the liver (CYP3A4). That is intentional — it keeps blood levels of the actual antiviral high. But it also means that many long-term medicines are suddenly broken down more slowly and can build up in the body, sometimes to dangerous levels. The very people Paxlovid is meant for — older patients and those with chronic conditions — often take several of these medicines.⁴
| Drug group | Examples | Why it is critical | Usual approach (medical decision only!) |
|---|---|---|---|
| Statins (cholesterol-lowering drugs) | Simvastatin, atorvastatin, lovastatin | Levels rise sharply — risk of muscle damage up to rhabdomyolysis | Pause or switch the statin for the duration of the treatment |
| Direct oral anticoagulants (DOACs) | Rivaroxaban, apixaban | Stronger effect — increased risk of bleeding | Depending on the drug: adjust the dose, switch, or do without Paxlovid |
| Vitamin K antagonists | Phenprocoumon | Clotting values can drift out of the target range | Close INR monitoring during and after the treatment |
| Immunosuppressants | Tacrolimus, ciclosporin | Levels can rise many times over — toxic effects are possible | Only with blood level monitoring and specialist supervision, often with a scheduled dose pause |
| Heart rhythm medicines | Amiodarone and other antiarrhythmics | Dangerous rhythm disturbances are possible | The combination is usually ruled out — an alternative to Paxlovid is then considered |
| Sleeping tablets, sedatives, strong painkillers | Midazolam, some opioids | Stronger sedation, up to respiratory depression | Case-by-case decision, sometimes dose adjustment, sometimes avoidance |
This table is only an excerpt — the product information lists well over a hundred relevant combinations.⁴ That is why a complete list of your medicines belongs on the table before any prescription, including over-the-counter products such as St John’s wort (which can weaken the effect of Paxlovid). The guide Keeping a medication list shows how to put such a list together; the background to interactions is explained in Drug interactions.
brite shows you your complete medication and warns you about risky combinations.
Most people can get over the illness at home. But there are warning signs you should not wait out:
In hospital further treatments are available — from oxygen and anticoagulation to anti-inflammatory medicines such as dexamethasone. These treatments belong in the clinic and nowhere else.³
If symptoms persist for more than four weeks after the infection or appear newly, this is called Long COVID; from three months onwards, post-COVID syndrome. Typical features are persistent exhaustion, problems with concentration (“brain fog”), intolerance of exertion and shortness of breath. One point matters for putting this in perspective: feeling tired and run down for one to two weeks after the infection is normal and is not yet Long COVID. But if you are still clearly below your usual level after weeks, or if your symptoms reliably worsen after exertion, read on in the article Long COVID and speak to your GP practice.
COVID-19 vaccination mainly protects against severe illness — protection against catching the virus at all is limited and wanes over time. In Germany, the Standing Committee on Vaccination (STIKO) currently recommends basic immunity built from several antigen contacts for all adults, plus annual booster vaccinations in autumn for people aged 60 and over, for people with underlying conditions or a weakened immune system, for residents of care homes and for healthcare staff.⁵ The booster can easily be combined with the flu vaccination at the same appointment. Which other vaccinations are due for you is covered in the guide Vaccinations for adults.
With the health history in brite you keep track of the infection and of your recovery.
Long-term medication, interactions and your symptom history in one place. Free.
Start free now